Autologous Adipose-derived Mesenchymal Stem Cell therapy(Institute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus)

N/A

Report date: 2023/01/12 15:46:26

Base Information

Drug NameAutologous Adipose-derived Mesenchymal Stem Cell therapy(Institute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsUlcer

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelarus

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

Active IndicationsN/A

Inactive IndicationsUlcer

Other Information

ATC CodeN/A